Tag: muscular

U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago. The ruling marks the second time the Food and Drug Administration has granted preliminary approval for the disease based on early results and is likely to

Congenital muscular torticollis (CMT) is a common postural deformity in infants, and one that can be effectively treated by physical therapy., A set of updated, evidence-based recommendations for physical therapy management of CMT is presented in the October issue of Pediatric Physical Therapy. Reflecting the latest research relevant to the prevention, screening, and intervention of

Promoting repair of dystrophic muscles is a major goal in the treatment of muscular dystrophies but is complicated by the incomplete knowledge of the cellular and molecular events that drive muscle regeneration. Answers could lie in better understanding muscle repair—which resembles a delicate cellular dance choreographed by special cells called fibro-adipogenic progenitors (FAPs). Researchers already

Scientists for the first time have used CRISPR gene editing to halt the progression of Duchenne muscular dystrophy (DMD) in a large mammal, according to a study by UT Southwestern that provides a strong indication that a lifesaving treatment may be in the pipeline. The research published in Science documents unprecedented improvement in the muscle

Scientists from the University of Jyväskylä, Finland, and from University of Cambridge, United Kingdom, have found new functions and structural details of muscle attachment structures. The research is important for the basic understanding of regulation of muscle function, for instance, in muscular dystrophy patients and for muscle adaptation in physical activity and sports. In multicellular

Spinal muscular atrophy (SMA) is a genetic disease that can leave infants with weak muscles and trouble breathing. Many with the disease die before age two. To help these patients, doctors need therapies that target the genetic mutation and stop its progression. Now, scientists at the California Institute for Biomedical Research (Calibr) and The Scripps